ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/10/2025
Back to search
Official data from USPTO
PHARMADAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
09/11/2025
Trademark type
Combined
Nice classes
5
Filing date
06/07/2018
Registration date
08/04/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/04/2020
Last transaction
09/11/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/01/2016
First use in commerce
03/01/2016
Drawing code
5
Owner type
03
Owner location
NEW TAIPEI CITY, TW
Examiner
DIBLE, IAN
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "PHARMADAX" in capital letters with "PHARMA" in bold letters and "DAX" in non-bold letters.
Holders and representatives
Holders
PHARMADAX INC.
Pharmadax USA, Inc.
Pharmadax USA, Inc.
Representatives
Scott E. Benfield HAYNES AND BOONE, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders
Publications
History of USPTO decisions and trademark events.
40 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/14/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/04/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/28/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/28/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/28/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/28/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/28/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/28/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
08/04/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/30/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/27/2020
EEXT
SOU TEAS EXTENSION RECEIVED
06/24/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/24/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/24/2020
ALIE
ASSIGNED TO LIE
06/21/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/15/2020
GNRT
NON-FINAL ACTION E-MAILED
01/15/2020
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/15/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/09/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/08/2020
EX2G
SOU EXTENSION 2 GRANTED
01/08/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/08/2020
IUAF
USE AMENDMENT FILED
12/30/2019
EXT2
SOU EXTENSION 2 FILED
12/30/2019
EEXT
SOU TEAS EXTENSION RECEIVED
12/30/2019
EISU
TEAS STATEMENT OF USE RECEIVED
12/30/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/02/2019
EX1G
SOU EXTENSION 1 GRANTED
06/28/2019
EXT1
SOU EXTENSION 1 FILED
06/28/2019
EEXT
SOU TEAS EXTENSION RECEIVED
06/28/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/01/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/06/2018
PUBO
PUBLISHED FOR OPPOSITION
11/06/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/17/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2018
DOCK
ASSIGNED TO EXAMINER
09/25/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/14/2018
NWAP
NEW APPLICATION ENTERED
06/11/2018
Continuous trademark protection
Get notified about every new filing that threatens PHARMADAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.